カテゴリー： QYResearch, 世界

世界のB細胞慢性リンパ性白血病の治療市場

◆英語タイトル：Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Professional Survey Report 2019
◆商品コード：DATA909X04451
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、B細胞慢性リンパ性白血病の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、その他に、用途別には、クリニック、病院、その他にセグメント区分し、B細胞慢性リンパ性白血病の治療の世界市場を分析しました。

・エグゼクティブ・サマリー
・B細胞慢性リンパ性白血病の治療の世界市場概要
・B細胞慢性リンパ性白血病の治療の製造コスト構成分析
・B細胞慢性リンパ性白血病の治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・B細胞慢性リンパ性白血病の治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・B細胞慢性リンパ性白血病の治療のセグメント分析（種類別）
（AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、その他）
・B細胞慢性リンパ性白血病の治療のセグメント分析（用途別）
（クリニック、病院、その他）
・B細胞慢性リンパ性白血病の治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AB Science SA、Amgen Inc.、Celgene Corporation、Dynavax Technologies Corporation、Eisai、Elsalys Biotech SAS、F. Hoffmann-La Roche Ltd.、iDD biotech SAS、Immunomedics, Inc.、Johnson & Johnson、Juno Therapeutics Inc.、Molecular Templates Inc.、Noxxon Pharma AG、）
・B細胞慢性リンパ性白血病の治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global B-Cell Chronic Lymphocytic Leukemia Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on B-Cell Chronic Lymphocytic Leukemia Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall B-Cell Chronic Lymphocytic Leukemia Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of B-Cell Chronic Lymphocytic Leukemia Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their B-Cell Chronic Lymphocytic Leukemia Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AB Science SA
Amgen Inc.
Celgene Corporation
Dynavax Technologies Corporation
Eisai
Elsalys Biotech SAS
F. Hoffmann-La Roche Ltd.
iDD biotech SAS
Immunomedics, Inc.
Johnson & Johnson
Juno Therapeutics Inc.
Molecular Templates Inc.
Noxxon Pharma AG

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
AMG-319
ATTCK-20
IDD-002
JNJ-64052781
Lenalidomide
MAT-303
MT-3724
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of B-Cell Chronic Lymphocytic Leukemia Treatment
1.1 Definition of B-Cell Chronic Lymphocytic Leukemia Treatment
1.2 B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Type
1.2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 AMG-319
1.2.3 ATTCK-20
1.2.4 IDD-002
1.2.5 JNJ-64052781
1.2.6 Lenalidomide
1.2.7 MAT-303
1.2.8 MT-3724
1.2.9 Others
1.3 B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Applications
1.3.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global B-Cell Chronic Lymphocytic Leukemia Treatment Overall Market
1.4.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (2014-2025)
1.4.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production (2014-2025)
1.4.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.5 China B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.6 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
1.4.8 India B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
2.3 Manufacturing Process Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
2.4 Industry Chain Structure of B-Cell Chronic Lymphocytic Leukemia Treatment

3 Development and Manufacturing Plants Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
3.1 Capacity and Commercial Production Date
3.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of B-Cell Chronic Lymphocytic Leukemia Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 B-Cell Chronic Lymphocytic Leukemia Treatment Production and Capacity Analysis
4.2 B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Analysis
4.3 B-Cell Chronic Lymphocytic Leukemia Treatment Price Analysis
4.4 Market Concentration Degree

5 B-Cell Chronic Lymphocytic Leukemia Treatment Regional Market Analysis
5.1 B-Cell Chronic Lymphocytic Leukemia Treatment Production by Regions
5.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production by Regions
5.1.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Regions
5.2 B-Cell Chronic Lymphocytic Leukemia Treatment Consumption by Regions
5.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.3.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.3.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.4.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.4.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.5 China B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.5.1 China B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.5.2 China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.6 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.6.1 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.6.2 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.7 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.7.1 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.7.2 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
5.8 India B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
5.8.1 India B-Cell Chronic Lymphocytic Leukemia Treatment Production
5.8.2 India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export

6 B-Cell Chronic Lymphocytic Leukemia Treatment Segment Market Analysis (by Type)
6.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production by Type
6.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Type
6.3 B-Cell Chronic Lymphocytic Leukemia Treatment Price by Type

7 B-Cell Chronic Lymphocytic Leukemia Treatment Segment Market Analysis (by Application)
7.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption by Application
7.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Market Share by Application (2014-2019)

8 B-Cell Chronic Lymphocytic Leukemia Treatment Major Manufacturers Analysis
8.1 AB Science SA
8.1.1 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.1.2 AB Science SA Product Introduction, Application and Specification
8.1.3 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen Inc.
8.2.1 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.2.2 Amgen Inc. Product Introduction, Application and Specification
8.2.3 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Celgene Corporation
8.3.1 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.3.2 Celgene Corporation Product Introduction, Application and Specification
8.3.3 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Dynavax Technologies Corporation
8.4.1 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.4.2 Dynavax Technologies Corporation Product Introduction, Application and Specification
8.4.3 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eisai
8.5.1 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.5.2 Eisai Product Introduction, Application and Specification
8.5.3 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Elsalys Biotech SAS
8.6.1 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.6.2 Elsalys Biotech SAS Product Introduction, Application and Specification
8.6.3 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 F. Hoffmann-La Roche Ltd.
8.7.1 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.7.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
8.7.3 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 iDD biotech SAS
8.8.1 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.8.2 iDD biotech SAS Product Introduction, Application and Specification
8.8.3 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Immunomedics, Inc.
8.9.1 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.9.2 Immunomedics, Inc. Product Introduction, Application and Specification
8.9.3 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Johnson & Johnson
8.10.1 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
8.10.2 Johnson & Johnson Product Introduction, Application and Specification
8.10.3 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Juno Therapeutics Inc.
8.12 Molecular Templates Inc.
8.13 Noxxon Pharma AG

9 Development Trend of Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment Market
9.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Trend Analysis
9.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 B-Cell Chronic Lymphocytic Leukemia Treatment Regional Market Trend
9.2.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.3 China B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.4 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.5 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.2.6 India B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
9.3 B-Cell Chronic Lymphocytic Leukemia Treatment Market Trend (Product Type)
9.4 B-Cell Chronic Lymphocytic Leukemia Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 B-Cell Chronic Lymphocytic Leukemia Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of B-Cell Chronic Lymphocytic Leukemia Treatment
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share by Types in 2018
Figure AMG-319 Product Picture
Figure ATTCK-20 Product Picture
Figure IDD-002 Product Picture
Figure JNJ-64052781 Product Picture
Figure Lenalidomide Product Picture
Figure MAT-303 Product Picture
Figure MT-3724 Product Picture
Figure Others Product Picture
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) (2014-2025)
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs) (2014-2025)
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) (2014-2025)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment in 2018
Figure Manufacturing Process Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
Figure Industry Chain Structure of B-Cell Chronic Lymphocytic Leukemia Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturing Plants Distribution
Table B-Cell Chronic Lymphocytic Leukemia Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table B-Cell Chronic Lymphocytic Leukemia Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure B-Cell Chronic Lymphocytic Leukemia Treatment Production Share by Manufacturers in 2018
Table B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Manufacturers in 2018
Table B-Cell Chronic Lymphocytic Leukemia Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Production by Regions 2014-2019 (K Pcs)
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share by Regions 2014-2019
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share by Regions in 2018
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Regions 2014-2019
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Regions in 2018
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Market Share by Regions 2014-2019
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India B-Cell Chronic Lymphocytic Leukemia Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2014-2019)
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Product Introduction, Application and Specification
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate (2014-2019)
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production Market Share (2014-2019)
Figure Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share (2014-2019)
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Main Business and Markets Served
Table Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Table Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of B-Cell Chronic Lymphocytic Leukemia Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of B-Cell Chronic Lymphocytic Leukemia Treatment by Application (2019-2025)
Table B-Cell Chronic Lymphocytic Leukemia Treatment Distributors List
Table B-Cell Chronic Lymphocytic Leukemia Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

AB Science SA、Amgen Inc.、Celgene Corporation、Dynavax Technologies Corporation、Eisai、Elsalys Biotech SAS、F. Hoffmann-La Roche Ltd.、iDD biotech SAS、Immunomedics, Inc.、Johnson & Johnson、Juno Therapeutics Inc.、Molecular Templates Inc.、Noxxon Pharma AG、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のB細胞慢性リンパ性白血病の治療市場(Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp